Dispute with “unlisted author whose claim to authorship could not be solved” topples cancer paper

cancreschCancer Science, the journal of the Japanese Cancer Association, has retracted a 2012 article by a group of researchers because, well, it wasn’t clear who made up the group in the first place.

The article,  “Antitumor activity of human γδ T cells transducted with CD8 and with T-cell receptors of tumor-specific cytotoxic T lymphocytes,” appeared online in July 2012 and was written, ostensibly, by Takeshi Hanagiri, Yoshiki Shigematsu, Koji Kuroda, Tetsuro Baba, Hironobu Shiota, Yoshinobu Ichiki, Yoshika Nagata, Manabu Yasuda, Tomoko So, Mitsuhiro Takenoyama and Fumihiro Tanaka from the Second Department of Surgery at the University of Occupational and Environmental Health, in Kitakyushu.

The abstract states: Continue reading Dispute with “unlisted author whose claim to authorship could not be solved” topples cancer paper

Shigeaki Kato up to 23 retractions

katoShigeaki Kato, the former University of Tokyo endocrinology researcher found to have manipulated images in dozens of papers, has six more retractions, bringing his total to 23.

Five of them appear in Molecular and Cellular Biology: Continue reading Shigeaki Kato up to 23 retractions

Shigeaki Kato notches retractions 16 and 17, in PNAS

katoShigeaki Kato has two more retractions, both in the Proceedings of the National Academy of Sciences (PNAS).

Here’s one of the notices: Continue reading Shigeaki Kato notches retractions 16 and 17, in PNAS

Japan officials allege data cooking in Alzheimer’s drug study

j-adniJapanese health officials are reportedly investigating whether researchers fabricated data in a 2.8 billion yen ($21.12 million) Alzheimer’s drug trial.

According to Japan Today:

Health officials said they were questioning researchers after being told false data was used in clinical testing for the 2.8 billion yen government-backed Alzheimer’s study, aimed at improving diagnosis of the disease. Continue reading Japan officials allege data cooking in Alzheimer’s drug study

Five more retractions appear for Shigeaki Kato

katoShigeaki Kato, the former University of Tokyo endocrinology researcher who resigned in 2012 and has retracted at least ten papers, by our count, has five more retractions.

Here are the papers, all in the Journal of Biological Chemistry (JBC): Continue reading Five more retractions appear for Shigeaki Kato

Cancer biology group notches sixth retraction, and earns an Expression of Concern

bjcA group at the University of Texas Southwestern that retracted five papers last year has retracted one more, and has had a paper subjected to an Expression of Concern at the request of the school’s dean.

Here’s the retraction notice for “DNA methylation-associated inactivation of TGFβ-related genes, DRM/Gremlin, RUNX3, and HPP1 in human cancers,” originally published in the British Journal of Cancer and cited 51 times, according to Thomson Scientific’s Web of Knowledge:
Continue reading Cancer biology group notches sixth retraction, and earns an Expression of Concern

Cell update: Co-corresponding author let go from Belgian university; retraction notice language changed

cell november 2013We’ve learned more about the circumstances behind a Cell retraction that we covered last week.

First, one of the two corresponding authors left the institution where he most recently worked. Belgium’s VIB Ghent told us that Pankaj Dhonukshe was no longer employed there and said: Continue reading Cell update: Co-corresponding author let go from Belgian university; retraction notice language changed

Holes in ASS as journal pulls two papers

asscoverThe journal Applied Surface Science (okay, so maybe it’s not called ASS at the home office) is retracting a pair of articles in its December issue.

The first, “Structure and mechanical properties of Ni–P electrodeposited coatings,” appeared in 2009 and was written by a group of researchers in Beijing. It has been cited nine times, according to Thomson Scientific’s Web of Knowledge. Its problem: Plagiarism. According to the retraction noticeContinue reading Holes in ASS as journal pulls two papers

Authors retract Cell paper amid ongoing investigation

cell november 2013The authors of a 2012 paper in Cell have retracted it after discovering “serious issues with several figures.”

Here’s the notice for “A PLETHORA-Auxin Transcription Module Controls Cell Division Plane Rotation through MAP65 and CLASP:” Continue reading Authors retract Cell paper amid ongoing investigation

Royal Society of Chemistry apologizes for unclear retraction notice

jaasLast week, we reported on a retraction in the Journal of Analytical Atomic Spectrometry that left us a bit puzzled. The notice referred to a problem with “the way the data was presented,” but the authors told us this was just an error picked up in proofreading, somehow after the paper had been published online.

We now have much more of the story. The Royal Society of Chemistry’s May Copsey, who edits the journal, tells Retraction Watch: Continue reading Royal Society of Chemistry apologizes for unclear retraction notice